Volume 79, Issue 1, Pages (January 2011)

Slides:



Advertisements
Similar presentations
Reduced renal function in patients with simple renal cysts
Advertisements

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease  Ryo Matsuura, Kenjiro.
Volume 54, Issue 2, Pages (August 1998)
Long-term evolution of cardiomyopathy in dialysis patients
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Recalcitrant pain in a patient with ADPKD
Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson 
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Volume 57, Issue 5, Pages (May 2000)
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
C-reactive protein and dialysis access
Volume 77, Issue 1, Pages 6-8 (January 2010)
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Better nephrology for mice—and man
Normalization of Protein Intake by Body Weight and the Associations of Protein Intake With Nutritional Status and Survival  Srinivasan Beddhu, MD, Nirupama.
Volume 75, Issue 12, Pages (June 2009)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 93, Issue 3, Pages (March 2018)
How to interpret the eGFR in patients with small body surface area
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
Volume 77, Issue 2, Pages (January 2010)
Volume 76, Issue 3, Pages (August 2009)
Volume 87, Issue 2, Pages (February 2015)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 74, Issue 9, Pages (November 2008)
Volume 70, Issue 12, Pages (December 2006)
Comparison of three methods to quantify urinary aquaporin-2 protein
Fructose intake as a risk factor for kidney stone disease
Volume 56, Issue 4, Pages (October 1999)
Response to ‘Hepcidin levels in patients with renal disease’
The promise of biomarkers for personalized renal cancer care
Progression of polycystic kidney disease in a kidney transplant
Volume 62, Issue 5, Pages (November 2002)
Volume 61, Issue 6, Pages (June 2002)
Extracorporeal therapy in sepsis: are we there yet?
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Volume 87, Issue 1, Pages (January 2015)
Long-term evolution of cardiomyopathy in dialysis patients
Reduced renal function in patients with simple renal cysts
Volume 78, Issue 5, Pages (September 2010)
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
Unilateral renal cystic disease
Volume 81, Issue 9, Pages (May 2012)
Harold M. Aukema, Ihsan Housini  Kidney International 
Prehypertension: is it relevant for nephrologists?
Homocysteine, renal function, and risk of cardiovascular disease
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 74, Issue 9, Pages (November 2008)
Volume 76, Issue 1, Pages (July 2009)
The course of the remnant kidney model in mice
Volume 80, Issue 10, Pages (November 2011)
Volume 74, Issue 9, Pages (November 2008)
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction  Malcolm F. Hand, William G. Haynes, David J.
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 1, Pages (January 2009)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 63, Pages S13-S16 (February 2003)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Volume 72, Issue 11, Pages (December 2007)
Volume 61, Issue 1, Pages (January 2002)
Volume 65, Issue 5, Pages (May 2004)
Volume 74, Issue 10, Pages (November 2008)
Volume 77, Issue 12, Pages (June 2010)
Volume 67, Issue 4, Pages (April 2005)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Volume 68, Issue 5, Pages (November 2005)
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Volume 79, Issue 1, Pages 128-134 (January 2011) Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease  Berenice Y. Reed, Amirali Masoumi, Elwaleed Elhassan, Kim McFann, Melissa A. Cadnapaphornchai, David M. Maahs, Janet K. Snell- Bergeon, Robert W. Schrier  Kidney International  Volume 79, Issue 1, Pages 128-134 (January 2011) DOI: 10.1038/ki.2010.355 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Scatter plot of serum log10 vascular endothelial growth factor (VEGF) and log10 total renal volume. The plot depicts the uncorrected relationship between renal volume and serum VEGF. VEGF pg/ml and renal volume mm3. Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Total renal volume expressed by quartile of serum vascular endothelial growth factor (VEGF) level. Renal volume was adjusted for age, sex, and body surface area. VEGF range <50th percentile <440pg/ml; 50–75th percentile 224–2750pg/ml; >75th percentile 2950–18,000pg/ml. All P-values were corrected for multiple comparisons by the Tukey–Kramer correction.21 Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Total cyst volume expressed by quartile of serum vascular endothelial growth factor (VEGF) level. Cyst volume was adjusted for age and sex. VEGF range/quartile as presented in legend for Figure 2. All P-values were corrected for multiple comparisons by the Tukey–Kramer correction.21 Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Scatter plot of serum angiopoietin (Ang)-1 and log10 urinary protein excretion. The plot depicts the uncorrected relationship between 24h urinary protein excretion and serum Ang-1 level. Ang-1 ng/ml and urinary protein g/24h. Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Creatinine clearance expressed by quartile of serum vascular endothelial growth factor (VEGF) level. Creatinine clearance was corrected for height and weight and VEGF range/quartile is presented in legend for Figure 1. All P-values were corrected for multiple comparisons by the Tukey–Kramer correction.21 Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 6 Scatter plot of serum log10 vascular endothelial growth factor (VEGF) and log10 left ventricular mass index (LVMI). The plot depicts the relationship between serum VEGF and LVMI. VEGF pg/ml and LVMI g/m2. Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 7 Left ventricular mass index (LVMI) expressed by quartile of serum vascular endothelial growth factor (VEGF) level. LVMI is already adjusted for body surface area, but age and sex were included as covariates. VEGF range/quartile as presented in legend for Figure 1. All P-values were corrected for multiple comparisons by the Tukey–Kramer correction.21 Kidney International 2011 79, 128-134DOI: (10.1038/ki.2010.355) Copyright © 2011 International Society of Nephrology Terms and Conditions